Abstract
An independent evaluation of the Affordable Medicine Facility for malaria (AMFm) pilot phase has hailed it as a success, but important limitations and unanswered questions remain. In 2012, the board of the Global Fund decided to integrate the AMFm into country grants by 2014. This means that countries now need to determine how much of available grant resources to spend on expanding access through the public sector and how much, if any, on subsidizing drugs in the private, for-profit sector. The assumption of the AMFm has assumed that improving delivery of artemisinin-based combination therapy through the private sector would be more efficient than further expanding access through the public sector and community health workers. But, the advantage of expanding and improving service delivery through the public sector and community health workers is that treatments can be effectively linked with diagnosis and that diagnosis and treatment can be offered for free.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
World Health Organization. (2012) World Malaria Report 2012. Geneva: WHO, http://www.who.int/malaria/publications/world_malaria_report_2012/wmr2012_no_profiles.pdf, accessed 24 February 2013.
Arrow, K.J. et al (2012) The Affordable Medicines Facility – Malaria: Killing it slowly. Lancet 380 (9857): 1889–1890.
Tougher, S. et al (2012) Effect of the Affordable Medicines Facility – Malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: A before-and-after analysis of outlet survey data. Lancet 380 (9857): 1916–1926.
Arnold, F. et al (2012) Final Report of the Independent Evaluation of AMFm Phase 1. Submitted to the Global Fund to Fight AIDS, Tuberculosis and Malaria, September, http://www.theglobalfund.org/en/amfm/independentevaluation/, accessed 25 February 2012.
Kamal-Yanni, M. (2012) Salt, Sugar, and Malaria Pills: How the Affordable Medicine Facility–Malaria Endangers Public Health. Oxfam Briefing Paper 163, http://www.oxfam.org/sites/www.oxfam.org/files/bp163-affordable-medicine-facility-malaria-241012-en.pdf, accessed 25 February 2013.
D'Acremont, V., Lengeler, C., Genton, B. (2009) Reduction in the proportion of fevers associated with Plasmodium falciparum parasitaemia in Africa: a systematic review. Malaria Journal 22 (9): 240, doi:10.1186/1475-2875-9-240.
Cohen, J.L., Yavuz, E., Morris, A., Arkedis, J. and Sabot, O. (2012) Do patients adhere to over-the-counter artemisinin combination therapy for malaria? Evidence from an intervention study in Uganda. Malaria Journal 11: 83, doi: 10.1186/1475-2875-11-83.
Kamal-Yanni, M., Potet, J. and Saunders, P. (2012) Scaling-up malaria treatment: A review of the performance of different providers. Malaria Journal 11: 414, doi: 10.1186/1475-2875-11-414.
Acknowledgements
I am grateful to James Arkinstall for helpful comments on the manuscript.
Author information
Authors and Affiliations
Additional information
This commentator critically examines the assumption of the AMFm that improving delivery of ACT through the private sector would be more efficient than further expanding access through the public sector and community health workers.
Rights and permissions
About this article
Cite this article
von Schoen-Angerer, T. Commentary: Learning all the lessons: Expanding access to malaria diagnosis and treatment. J Public Health Pol 34, 315–319 (2013). https://doi.org/10.1057/jphp.2013.15
Published:
Issue Date:
DOI: https://doi.org/10.1057/jphp.2013.15